Located in Suzhou, Porton Biologics Ltd. (Portonbio) was established in 2018. As a wholly-owned subsidiary of Porton Pharma Solutions Ltd, Portonbio is committed to providing end-to-end gene/therapy CDMO service for innovators from the early stage, IND filling and even commercial production in order to advance clients’ product into clinics and beyond.